ConductScience.org, home

Trial · NCT07898969

Effects of Cognitive Restructuring Intervention on Competitive State Anxiety and Volleyball Skill Performance Among Female Collegiate Volleyball Players in Guangzhou, China

NCT07898969, Not applicable, Not yet recruiting, Lyu Botao

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effects of Cognitive Restructuring Intervention on Competitive State Anxiety and Volleyball Skill Performance Among Female Collegiate Volleyball Players in Guangzhou, China. Trials, record NCT07898969. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898969

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of Cognitive Restructuring Intervention on Competitive State Anxiety and Volleyball Skill Performance Among Female Collegiate Volleyball Players in Guangzhou, China
NCT number
NCT07898969
Status
Not yet recruiting
Phases
Not applicable
Enrollment
96 participants, estimated
Lead sponsor
Lyu Botao
Conditions
Competitive State Anxiety, Volleyball Skill Performance
Interventions
Cognitive Restructuring Intervention, Volleyball Referee-Signal Instruction
First posted
2026-10-27
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCompetitive State Anxiety Assessed by the Chinese CSAI-2
Baseline (T0, before the intervention), mid-intervention assessment (T1, week 4), and post-intervention assessment (T2, week 8). The CSAI-2 will be completed 10-12 minutes before the volleyball skill tests at each assessment.
Competitive state anxiety will be assessed using the Chinese version of the Competitive State Anxiety Inventory-2 (CSAI-2), including cognitive anxiety, somatic anxiety and state self-confidence. The primary analysis will examine changes in CSAI-2 scores over time and compare these changes between the cognitive restructuring group and the neutral volleyball referee-instruction group.
PrimaryVolleyball Skill PerformanceBaseline (T0), mid-intervention assessment (T1, week 4), and post-intervention assessment (T2, week 8).
Volleyball skill performance will be assessed using standardized volleyball skill tests adapted from the U18 and libero technical-test criteria of the China Youth Volleyball Teaching and Training Outline (2026) and Volleyball Management Center (2026). The assessment includes five skill domains: serving, reception, spiking, blocking, and defence. Each domain will be scored from 0 to 10 points by combining task achievement or quality (50%) and technical quality (50%). The five domain scores will be summed to produce a total volleyball skill-performance score ranging from 0 to 50 points, with higher scores indicating better performance. Tests will be conducted at baseline (T0), mid-intervention (T1, week 4), and post-intervention (T2, week 8) using standardized procedures and trained raters.
SecondarySleep Quality Assessed by the Chinese Pittsburgh Sleep Quality IndexBaseline assessment (T0) before the intervention.
Sleep quality will be assessed using the Chinese version of the Pittsburgh Sleep Quality Index (PSQI). The PSQI evaluates subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication and daytime dysfunction. The PSQI score will be used as a baseline control variable in the analysis, with higher scores indicating poorer sleep quality.
SecondaryTrait Sport Anxiety Assessed by the Chinese SAS-2Baseline (T0), mid-intervention assessment (T1, week 4), and post-intervention assessment (T2, week 8).
Sport anxiety will be assessed using the validated Chinese version of the Sport Anxiety Scale-2 (SAS-2) at baseline, mid-intervention, and post-intervention assessments. The 15-item scale measures worry, somatic anxiety, and concentration disruption. Each item is scored from 1 to 4, and total and subscale scores will be calculated according to the validated scoring procedure. Higher scores indicate greater sport anxiety. Changes in SAS-2 scores over time and differences between the cognitive restructuring group and the neutral volleyball referee-instruction group will be analyzed as a secondary outcome.
SecondaryMental Effort Assessed by the Rating Scale of Mental Effort (RSME)Baseline (T0), mid-intervention assessment (T1, week 4), and post-intervention assessment (T2, week 8).
Mental effort during the volleyball skill tests will be assessed using the Rating Scale of Mental Effort (RSME). The RSME score will be recorded after each assessment session, with higher scores indicating greater perceived mental effort.
OtherProcessing Efficiency Index (PEI)At baseline, mid-intervention assessment (T1, week 4), and post-intervention assessment (T2, week 8), after completion of the volleyball skill test and RSME assessment.
An exploratory derived index calculated from standardized overall volleyball skill performance and Rating Scale Mental Effort (RSME) scores. PEI will be calculated as z-standardized overall volleyball skill performance minus z-standardized RSME score: PEI = z(skill performance) - z(RSME). Higher values indicate relatively better skill performance achieved with lower perceived mental effort. Overall skill performance and RSME scores will also be analyzed separately. No clinical cut-off value will be used.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07898969

GET https://conductscience.org/api/trials/v1/NCT07898969/registered